EUVIMEDEUVIMED entdecken
Crossref

HPV low-risk associated squamous cell carcinoma of the cervix uteri

L-C Horn, A Kunze, C Tennstedt-Schenk, U Kerlikowski, W Freiesleben, M Stiller, N Schöneberg, GG R Hiller, A-K Höhn

Geburtshilfe und Frauenheilkunde · 01.06.2026 · 86 (06) · e39-e40

DOI: 10.1055/s-0046-1823720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.06.2026. Verfasst von L-C Horn und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The vast majority of cervical squamous cell carcinoma (CSCC) are attributed to HPV high-risk infection. There is rising evidence of HPV-independent CSCC. More recently, anogenital malignancies, associated with low-risk HPV were described.

Methods

Histopathologic, immunohistochemical (p53, p16) and molecular analyses (HPV-DNA, NGS) with follow up information.

Results

The first case (35 YO) showed a conisation specimen with an intramucosal papillary exophytic pale squamous proliferation (1.2cm).On immunostaining there was a patchy non-block positivity for p16 and p53-wildtype staining. On molecular level HPV low-risk DNA was detected (HPV 6) and a class 5 TERT-promotor mutation on NGS-analysis. Subsequent hysterectomy represented no residual disease with no evidence of disease for 38 months. The second patient (70 YOA) presented with ASCUS on Pap smear and papillary non-keratinising squamous lesions (>1cm), at the uterine cervix with non-block positivity for p16 and p53-wildtype staining. 52 months later there was a vaginal recurrency with the same morphology (non-block positivity for p16 and p53-wildtype). Molecularly, that lesion represented HPV 11 low-risk DNA and a class 5 TERT-promotor mutation.

Conclusions

There is an increasing evidence of ano-genital neoplasms associated with HPV low-risk infection (mainly HPV 6; 11 and 42). A recent study reported HPV 6 and HPV 11 associated vulvar and cervical SCC mainly associated with mutations in TERT promotor (pTERT, 71%), NOTCH1 (57%) and NFE2L2 (57%), followed by NOTCH3 (29%), and CDKN2A (29%). Publication History Article published online: 10 June 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Horn, L., Kunze, A., Tennstedt-Schenk, C., Kerlikowski, U., Freiesleben, W., Stiller, M., Schöneberg, N., Hiller, G. R., & Höhn, A. (2026). HPV low-risk associated squamous cell carcinoma of the cervix uteri. Geburtshilfe und Frauenheilkunde, 86(06), e39-e40. https://doi.org/10.1055/s-0046-1823720

Vancouver

Horn L, Kunze A, Tennstedt-Schenk C, Kerlikowski U, Freiesleben W, Stiller M, et al. HPV low-risk associated squamous cell carcinoma of the cervix uteri. Geburtshilfe und Frauenheilkunde. 2026;86(06):e39-e40. doi:10.1055/s-0046-1823720

BibTeX
@article{Horn2026,
  author = {Horn, L-C and Kunze, A and Tennstedt-Schenk, C and Kerlikowski, U and Freiesleben, W and Stiller, M and Schöneberg, N and Hiller, GG R and Höhn, A-K},
  title = {HPV low-risk associated squamous cell carcinoma of the cervix uteri},
  journal = {Geburtshilfe und Frauenheilkunde},
  year = {2026},
  volume = {86},
  number = {06},
  pages = {e39--e40},
  doi = {10.1055/s-0046-1823720}
}
Kostenlos starten →